{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T22:27:47Z","timestamp":1764714467321},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1353,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.jcin.2009.09.002","type":"journal-article","created":{"date-parts":[[2009,11,18]],"date-time":"2009-11-18T15:23:11Z","timestamp":1258557791000},"page":"1074-1082","source":"Crossref","is-referenced-by-count":75,"title":["Prognostic Impact of Periprocedural Bleeding and Myocardial Infarction After Percutaneous Coronary Intervention in Unselected Patients"],"prefix":"10.1016","volume":"2","author":[{"given":"Jason B.","family":"Lindsey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven P.","family":"Marso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua M.","family":"Stolker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charanjit","family":"Rihal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Barsness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Piana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal S.","family":"Kleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2009.09.002_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1001\/jama.1997.03550060055036","article-title":"Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention","volume":"278","author":"Topol","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.09.002_bib2","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-8703(03)00095-4","article-title":"Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb\/IIIa antagonist era","volume":"145","author":"Ghazzal","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.09.002_bib3","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0735-1097(03)01044-1","article-title":"Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention","volume":"42","author":"Ioannidis","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/hc0502.104278","article-title":"Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?","volume":"105","author":"Akkerhuis","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.09.002_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib6","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.jacc.2007.02.027","article-title":"Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial","volume":"49","author":"Manoukian","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.amjcard.2007.06.026","article-title":"Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial","volume":"100","author":"Feit","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.106.612812","article-title":"Adverse impact of bleeding on prognosis in patients with acute coronary syndromes","volume":"114","author":"Eikelboom","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.09.002_bib9","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ahj.2004.11.012","article-title":"Predictors and 1-year outcome of major bleeding in patients with non\u2013ST-elevation acute coronary syndromes: insights from the Canadian Acute Coronary Syndrome registries","volume":"150","author":"Segev","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.09.002_bib10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib11","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0002-9149(03)00972-X","article-title":"Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions","volume":"92","author":"Kinnaird","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jama.1997.03540300029029","article-title":"Prognostic implication of creatine kinase elevation following elective coronary artery interventions","volume":"277","author":"Kong","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2009.09.002_bib13","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1161\/01.CIR.94.7.1528","article-title":"Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions","volume":"94","author":"Abdelmeguid","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.09.002_bib14","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00048","article-title":"Assessing quality using administrative data","volume":"127","author":"Iezzoni","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib15","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jacc.2008.01.054","article-title":"Patterns of cardiac marker surveillance after elective percutaneous coronary intervention and implications for the use of periprocedural myocardial infarction as a quality metric: a report from the National Cardiovascular Data Registry (NCDR)","volume":"51","author":"Wang","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib16","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.ahj.2005.03.030","article-title":"Design of a registry to characterize \u201creal-world\u201d outcomes of percutaneous coronary revascularization in the drug-eluting stent era","volume":"150","author":"Jacob","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2009.09.002_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9149(96)00773-4","article-title":"Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial)","volume":"79","author":"Bovill","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib18","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCINTERVENTIONS.108.825323","article-title":"Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-Sponsored, Multicenter 1985\u20131986 PTCA and 1997\u20132006 Dynamic Registries","volume":"2","author":"Venkitachalam","year":"2009","journal-title":"Circ Cardiovasc Intervent"},{"key":"10.1016\/j.jcin.2009.09.002_bib20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/eurheartj\/ehm019","article-title":"Bleeding and blood transfusion issues in patients with non\u2013ST-segment elevation acute coronary syndromes","volume":"28","author":"Rao","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2009.09.002_bib21","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/CIRCULATIONAHA.104.483297","article-title":"Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005?","volume":"112","author":"Bhatt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2009.09.002_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jcin.2008.10.008","article-title":"There will be blood","volume":"2","author":"Doyle","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2009.09.002_bib24","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.jcin.2009.09.002_bib26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(96)10452-9","article-title":"Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2009.09.002_bib27","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199808133390704","article-title":"Inhibition of platelet glycoprotein IIb\/IIIa with eptifibatide in patients with acute coronary syndromes","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJMoa0802944","article-title":"Bivalirudin versus unfractionated heparin during percutaneous coronary intervention","volume":"359","author":"Kastrati","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib29","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2009.09.002_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jcin.2008.05.007","article-title":"Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry","volume":"1","author":"Rao","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2009.09.002_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jcin.2007.12.006","article-title":"Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005","volume":"1","author":"Doyle","year":"2008","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2009.09.002_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1540-8183.2008.00351.x","article-title":"Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications","volume":"21","author":"Fitts","year":"2008","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib33","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.jacc.2007.07.028","article-title":"Vascular closure devices: the second decade","volume":"50","author":"Dauerman","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2009.09.002_bib34","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809005937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879809005937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T04:58:38Z","timestamp":1544849918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879809005937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1936879809005937"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2009.09.002","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}